Prostamax 22 MG

$60.00

Prostamax is a synthetic tetrapeptide bioregulator peptide primarily researched for its potential anti-aging, anti-inflammatory, and restorative effects on the prostate gland and other tissues. It is part of the Khavinson family of peptides, known for their influence on DNA condensation and epigenetic regulation.

Key pharmacokinetic and stability characteristics and research highlights of Prostamax include:

• Prostamax affects DNA condensation by decondensing heterochromatin, thus enabling greater gene expression, which may translate into enhanced cellular function, proliferation, and reduced apoptosis.
• Research in animal models, particularly rats, shows that Prostamax improves prostate histology, reduces fibrosis, and alleviates inflammation related to chronic prostatitis.
• The peptide also modulates lymphocyte function by opening chromatin and increasing ribosome expression, supporting enhanced protein synthesis and immune regulation.
• It is thought to influence androgen receptor signaling, inflammatory mediators, and oxidative stress pathways, contributing to improved tissue resilience and cellular homeostasis.
• Prostamax is supplied as a high-purity lyophilized powder with good metabolic stability under recommended refrigerated storage conditions; however, detailed pharmacokinetic parameters such as plasma half-life are not widely published.
• The peptide’s size (tetrapeptide) and synthetic design suggest relatively favorable stability and reasonable bioavailability for in vitro and ex vivo experimental use.
• Prostamax is intended exclusively for laboratory research use, not for clinical or therapeutic application.

Product details:

• Amino Acid Sequence: Lys-Glu-Asp-Pro (KEDP)
• Molecular Weight: Approximately 487.5 Da
• Purity: ≥98% (HPLC verified)
• Appearance: White to off-white lyophilized powder
• Storage: 2–8°C, protect from moisture and light

Prostamax represents a promising research peptide for studying prostate health, cellular aging, immune modulation, and epigenetic regulation in experimental models.

In stock

Prostamax is a peptide bioregulator under research for its potential to support prostate health and regulate gene expression in prostatic tissues.